ATE418563T1 - Nik proteine, nukleinsäure sowie verfahren - Google Patents

Nik proteine, nukleinsäure sowie verfahren

Info

Publication number
ATE418563T1
ATE418563T1 AT98934252T AT98934252T ATE418563T1 AT E418563 T1 ATE418563 T1 AT E418563T1 AT 98934252 T AT98934252 T AT 98934252T AT 98934252 T AT98934252 T AT 98934252T AT E418563 T1 ATE418563 T1 AT E418563T1
Authority
AT
Austria
Prior art keywords
nik
methods
disclosed
nucleic acid
nik proteins
Prior art date
Application number
AT98934252T
Other languages
English (en)
Inventor
Mike Rothe
Lin Wu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE418563T1 publication Critical patent/ATE418563T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98934252T 1997-07-03 1998-07-02 Nik proteine, nukleinsäure sowie verfahren ATE418563T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/887,518 US5843721A (en) 1997-07-03 1997-07-03 Nucleic acids encoding human NIK protein

Publications (1)

Publication Number Publication Date
ATE418563T1 true ATE418563T1 (de) 2009-01-15

Family

ID=25391324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98934252T ATE418563T1 (de) 1997-07-03 1998-07-02 Nik proteine, nukleinsäure sowie verfahren

Country Status (9)

Country Link
US (3) US5843721A (de)
EP (1) EP1012174B1 (de)
JP (1) JP2001510348A (de)
AT (1) ATE418563T1 (de)
AU (1) AU724178B2 (de)
CA (1) CA2295999C (de)
DE (1) DE69840387D1 (de)
ES (1) ES2319938T3 (de)
WO (1) WO1999001471A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування
EP0920518A1 (de) * 1996-08-26 1999-06-09 Signal Pharmaceuticals, Inc. Von einem stimulus induzierbarer i(kappa)b kinase komplex
US6235512B1 (en) * 1997-07-01 2001-05-22 Tularik Inc. IKK-α proteins, nucleic acids and methods
US5851812A (en) * 1997-07-01 1998-12-22 Tularik Inc. IKK-β proteins, nucleic acids and methods
US6087169A (en) * 1997-08-04 2000-07-11 Smithkline Beecham Plc HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide
US6242253B1 (en) * 1997-10-09 2001-06-05 Regents Of The University Of California IkB kinase, subunits thereof, and methods of using same
US6265538B1 (en) * 1998-02-27 2001-07-24 The Regents Of The University Of California Inhibitor of the inflammatory response induced by the TNFA and IL-1
US6830884B1 (en) * 1998-12-15 2004-12-14 Molecular Staging Inc. Method of amplification
US6468755B1 (en) 1999-08-10 2002-10-22 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
US6630312B2 (en) 1999-08-10 2003-10-07 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
US6649654B1 (en) * 1999-11-23 2003-11-18 The Regents Of The University Of California Methods for identifying and using IKK inhibitors
BR0109161A (pt) * 2000-03-15 2002-11-26 Aventis Pharma Gmbh Beta-carbolinas substituìdas com atividade de inibição de ikb-quinase
WO2001068648A1 (en) * 2000-03-15 2001-09-20 Aventis Pharma Deutschland Gmbh Substituted beta-carbolines with ikb-kinase inhibiting activity
EP1209158A1 (de) * 2000-11-18 2002-05-29 Aventis Pharma Deutschland GmbH Substitutierte beta-Carboline
US20030044852A1 (en) * 2000-08-10 2003-03-06 Joslin Diabetes Center, Inc., A Massachusetts Corporation Methods for treatment of insulin resistance
EP2333543B1 (de) 2000-09-26 2018-01-10 Health Research, Incorporated Analyse der hiv-1 co-rezeptorsverwendung zur klinischen auswertung von hiv-infizierten patienten
DE60133758T2 (de) * 2000-10-26 2009-07-02 Amgen Inc., Thousand Oaks Antiphlogistische mittel
US20050227228A1 (en) * 2001-06-05 2005-10-13 Lori Friedman Map3ks as modifiers of the p53 pathway and methods of use
NZ530765A (en) 2001-06-26 2006-11-30 Amgen Fremont Inc Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
WO2003087374A1 (en) * 2002-04-18 2003-10-23 Yeda Research And Development Co. Ltd. Derivatives of the il-2 receptor gamma chain, their production and use.
US7459273B2 (en) * 2002-10-04 2008-12-02 Affymetrix, Inc. Methods for genotyping selected polymorphism
WO2004060911A2 (en) 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
CA2541535C (en) * 2003-10-07 2013-12-10 Yeda Research And Development Co. Ltd. Antibodies to nik, their preparation and use
IL158287A0 (en) * 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
US8034340B2 (en) 2003-11-30 2011-10-11 Yeda Research And Development Ltd. Method for treating an immune disorder by decreasing NIK-SIVA complex formation
WO2005055804A2 (en) * 2003-12-02 2005-06-23 Musc Foundation For Research Development Methods and compositions for diagnosing epithelial cell cancer
WO2005084254A2 (en) * 2004-02-27 2005-09-15 Musc Foundation For Research Development Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription
EP2468889A3 (de) 2004-07-09 2012-07-11 University of Pittsburgh of the Commonwealth System of Higher Education Identifizierung von Markern für Lungen- und Brustkrebs
IL166006A0 (en) * 2004-12-27 2006-01-15 Yeda Res & Dev Pharmaceutical compositions for treating diseases associated with nf-kb activity
IL173104A0 (en) * 2006-01-12 2006-06-11 Yeda Res & Dev Siva and ubiquintination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0604560B1 (de) * 1991-09-20 2004-08-11 Fred Hutchinson Cancer Research Center Menschliches cyclin e
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування

Also Published As

Publication number Publication date
CA2295999C (en) 2004-04-27
US5844073A (en) 1998-12-01
DE69840387D1 (de) 2009-02-05
EP1012174B1 (de) 2008-12-24
EP1012174A4 (de) 2002-07-03
CA2295999A1 (en) 1999-01-14
AU724178B2 (en) 2000-09-14
AU8382098A (en) 1999-01-25
ES2319938T3 (es) 2009-05-14
US5843721A (en) 1998-12-01
WO1999001471A9 (en) 2008-04-17
EP1012174A1 (de) 2000-06-28
JP2001510348A (ja) 2001-07-31
US5854003A (en) 1998-12-29
WO1999001471A1 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
PT973794E (pt) Receptores de netrina
CA2281895A1 (en) Ikb kinases
DE69826493D1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
ATE300619T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
WO2001064877A3 (en) Human schizophrenia gene
DE69816467D1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
WO1998006841A3 (en) Two human nsp-like proteins
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
CA2294476A1 (en) Semaphorin receptors
WO1998011234A3 (en) Human protein kinases
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
WO2001064876A3 (en) Human schizophrenia gene
WO2002062964A3 (en) Ap1 amine oxidase variants
ATE278011T1 (de) Human dnase ii
DK0811068T3 (da) Humane DNase I varianter
WO1998012220A3 (en) Novel tumor proteins
WO2005003289A3 (en) Ap1 amine oxidase variants
EP1074619A3 (de) Promoter für Neuropeptide FF und Anwendung davon für Therapie und Nachweis
EP1219706A3 (de) Verfahren zur Herstellung von rekombinanterAsparaginase aus Wollinella Succinogenes
WO2002050116A3 (en) Adhesion molecule protein
WO2000053734A3 (de) Menschliche angiogeneserelevante nukleinsäure- und protein-sequenzen aus endothelzellen
WO2000050868A3 (en) Generation of diagnostic tools to assay the human lhx3/p-lim/lim-3 factor
WO2003044160A3 (en) Novel molecules of the card related protein family and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties